June 23, 2020 / 9:21 AM / 14 days ago

BRIEF-Xintela Granted Preliminary Approval From European Patent Office

June 23 (Reuters) - Xintela AB:

* XINTELA GRANTED PRELIMINARY APPROVAL FROM THE EUROPEAN PATENT OFFICE FOR THE TREATMENT OF BRAIN TUMORS

* PATENT, WHICH BROADENS AND EXTENDS XINTELA’S FUNDAMENTAL PROTECTION IN THIS FIELD, WILL BE VALID UNTIL 2036.

* EUROPEAN PATENT OFFICE (EPO) HAS ISSUED A PRELIMINARY APPROVAL (“INTENTION TO GRANT”) FOR COMPANY’S PATENT APPLICATION Source text for Eikon: Further company coverage: (Gdansk Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below